SITC - 2023 Primer on Tumor Immunology and Cancer Immunotherapy ABIM MOC
How would you like your name to appear on your certificate?
Profession
Select Your Profession
Other
Physician
Next
What activities did you attend at the event?
Thursday, November 2, 2023 - 8:15 am - 8:45 am
-- Select an Activity --
Adaptive Immune Responses to Cancer
Thursday, November 2, 2023 - 8:45 am - 9:15 am
-- Select an Activity --
T Cell Infiltration and Function in Solid Tumors
Thursday, November 2, 2023 - 9:15 am - 9:40 am
-- Select an Activity --
Innate Lymphocytes and Natural Killer Cells in Cancer Immunity
Thursday, November 2, 2023 -9:40 am - 10:05 am
-- Select an Activity --
The Role of Dendritic Cells in Cancer
Thursday, November 2, 2023 - 10:05 am - 10:30 am
-- Select an Activity --
B Cells and Tertiary Lymphoid Structures in Cancer: The Knowns and the Knowledge Gaps
Thursday, November 2, 2023 - 10:40 am - 11:05 am
-- Select an Activity --
Targeting Tregs in Tumors
Thursday, November 2, 2023 - 11:05 am - 11:30 am
-- Select an Activity --
Stromal Modulation of the Immune Tumor Microenvironment
Thursday, November 2, 2023 - 11:30 am - 11:55 am
-- Select an Activity --
Metabolism in Cancer Immunology
Thursday, November 2, 2023 - 11:55 am - 12:20 pm
-- Select an Activity --
Immunosuppressive Myeloid Cells: Unraveling Complexity to Achieve Rational Therapeutic Targeting
Thursday, November 2, 2023 - 1:40 pm - 2:10 pm
-- Select an Activity --
Vaccines as Initiators of the Cancer-Immunity Cycle
Thursday, November 2, 2023 - 2:10 om - 2:35 pm
-- Select an Activity --
Immune Checkpoint Therapy in Cancer
Thursday, November 2, 2023 - 2:35 pm - 3:00 pm
-- Select an Activity --
Efficacy and Toxicity with CAR-T and CAR-NK Cell Therapies
Thursday, November 2, 2023 - 3:00 pm - 3:25 pm
-- Select an Activity --
Modulating the Tumor Microenvironment with T Cell Bispecifics
Thursday, November 2, 2023 - 3:40 pm - 4:05 pm
-- Select an Activity --
Biomarkers of Response to Immune Checkpoint Therapies
Thursday, November 2, 2023 - 4:05 pm - 4:30 pm
-- Select an Activity --
Developing Personalized Cancer Vaccines
Thursday, November 2, 2023 - 4:30 pm - 4:55 pm
-- Select an Activity --
Cancer and the Microbiota: Understanding its Role in Immunotherapy Response
Thursday, November 2, 2023 -4:55 pm - 5:20 pm
-- Select an Activity --
Modifiable Physiological Factors that Impact Response to Immunotherapy
Previous
Next
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
I agree
Previous
Next
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.
Excellent
Very Good
Good
Fair
Poor
Previous
Next
Objective 1: Describe the key principles of cancer immunology and immunotherapy in the context of the cancer immunity cycle.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
The teaching methods used were appropriate to the objectives
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Previous
Next
What is your professional role? (Select all that apply)
Administration
Allergist
Clinician/Practicing Oncologist
Dermatologist
Emergency Physician
Endocrinologist
Industry: Advocacy/Public Affairs
Industry: Biostatistician
Industry: Medical Affairs
Industry: Research
Medical Oncologist
Nurse
Nurse Practitioner
Pathologist
Patient/Caregiver
Pharmacist
Physician Assistant
Primary Care Physician
Radiation Oncologist
Rheumatologist
Scientific Research
Scientist-in-Training/Student
Social Worker
Surgeon
Urologist
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
The teaching methods used were appropriate to the objectives
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
Previous
Next
If your professional role was not listed, above, please list it here:
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
The teaching methods used were appropriate to the objectives
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
Previous
Next
Which of the following best describes your primary work setting?
Academic Medical Center
Clinic Group Independent
Clinic Group Owned
Community Hospital with Training Program
Community Hospital without Training Program
Foundation
Government/Regulatory
Industry/Biotech (1-50 Employees)
Industry/Biotech (51-500 Employees)
Industry/Biotech (500+ Employees)
Investor
Non-Medical Academic Center
Non-Profit
Patient Advocacy Organization
Patient/Caregiver
Solo Private Practice
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
The teaching methods used were appropriate to the objectives
Strongly Agree
Agree
I don't know
Disagree
Strongly Disagree
Previous
Next
What is your area of specialization?
Antibody-Based Therapies
Biochemistry
Bioinformatics
Cellular Therapies
Cytokines
Clinical Investigations/Clinical Trials
Dermatology
Drug Development
Endocrinology
Gastroenterology
Genetics and Genomics
Gynecologic Oncology
Hematology
Immunology
Immuno-Oncology
Immunotherapy
Internal Medicine
Medical Oncology
Microbiology and Infectious Diseases
Molecular Biology
Neuro-oncology
Oncolytic Virus/Vaccines
Pathology
Pharmacology/Toxicology
Radiation Biology/ Radiation Oncology
Research Administration
Stem Cell Biology
Surgical Oncology
Transplantation
Urology
Previous
Next
If your area of specialization was not listed above, please list it here:
Previous
Next
How long have you been in practice (if applicable)?
More than 20 years
11 - 20 years
6 - 10 years
1 - 5 years
Less than 1 year
I do not directly provide care
Previous
Next
How many patients with cancer do you currently see each week (if applicable)?
Less than 5
5 - 15
16 - 25
26 - 35
36 - 45
46 - 55
56 or more
I do not directly provide care
Previous
Next
Please select the extent to which you agree/disagree that the activity supported the achievement of each learning objective:
Describe the key principles of tumor immunology and immunotherapy
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Summarize the basic principles of passive immonotherapy, in which antibodies or T lymphocytes generated outside of the patient are administered with therapeutic intent
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Discuss the techniques involved in active immunotherapy, including tumor antigen vaccintation as well as immune checkpoint blockade
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Outline immune monitoring techniques, both in peripheral blood and sera, as well as in patient samples collected in pre-surgical trials
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Enhance scientific exchange with colleagues and collaborators on research and application of cancer immunotherapies to improve outcomes of patients with cancer
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Previous
Next
Please select the extent to which you agree/disagree that the activity achieved the following:
The activity enhanced my current knowledge base.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
The educational material provided useful information for my practice or research.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
The content of this activity was fair, balanced, objective, and free of bias.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
The faculty were effective in presenting materials.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
The content was evidence based.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.).
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity).
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
N/A
Previous
Next
If you perceived commercial bias, please indicate the presenter and topic.
Previous
Next
Based upon your participation in this activity, do you intend to change your practice behavior? (Choose one of the following options.)
I do plan to implement changes in my practice based on the information presented.
My current practice has been reinforced by the information presented.
I need more information before I will change my practice.
Previous
Next
If you intend to change your approach to patient management, how confident are you that you will be able to make your intended changes?
Apply latest guidelines
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
I will be more likely to refer a patient to a clinical trial
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Change in pharmacological therapy
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Change in non-pharmacological therapy
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Change in diagnostic testing (e.g. biomarker testing)
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Change in how or when I refer patients to other specialists
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Change in how or when I ask my patients about symptoms indicative of irAEs
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
I will be more likely to combine different immune-based therapies (together or with other agents)
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Seek additional support to initiate IO treatment
Very Confident
Somewhat Confident
Unsure
Not Very Confident
N/A
Previous
Next
If you need more information before you are able to change your approach to patient management, what information would be helpful?
Previous
Next
Thinking about how your participation in this activity will influence your patient care, how many of your patients are likely to benefit in the next 3 months?
Fewer than 50
50 - 99
100 - 149
150 - 199
200 or more
N/A
Previous
Next
Which of the following do you anticipate will be the primary barrier to implementing these changes?
Formulary restrictions
Time constraints
System constraints (healthcare system or other)
Patient adherence/compliance
Lack of multidisciplinary support
Insurance/financial issues
Treatment of related adverse events
Other
Previous
Next
Would you recommend this program to a colleague?
Yes
No
Previous
Next
What other topics would you like to see addressed at the SITC Primer on Tumor Immunology and Cancer Immunotherapy?
Previous
Next
How did you first hear about this program?
SITC email
SITC website
Social media (Twitter, LinkedIn, Facebook)
Postcard
Word of mouth
Other
Previous
Next
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything:
Previous
Next
Please provide your name, email address and area of interest should you wish to be more involved in SITC or would like to become a member.
Previous
Next
Please leave additional feedback on how SITC can improve your experience next year.
Previous
Next
Did this program improve your Skill or Strategy in your role or contribution as a member of the healthcare team?
Yes
No
If no, why not?
Previous
Next
Do you believe your participation in this activity will positively impact your healthcare team?
Yes
No
Why or why not?
Previous
Next
ABIM: If you do not provide your Member Number AND your DATE OF BIRTH, your hours cannot be uploaded to PARS.
Previous
Next
(ABIM) Member Number - Example 123456:
Previous
Next
(ABIM) Date of Birth (MM/DD) - Example September 24 would be 0924
Previous